Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Feasibility of PRIME: A Cognitive Neuroscience-Informed Mobile App Intervention to Enhance Motivated Behavior and Improve Quality of Life in Recent Onset Schizophrenia.

Schlosser D, Campellone T, Kim D, Truong B, Vergani S, Ward C, Vinogradov S.

JMIR Res Protoc. 2016 Apr 28;5(2):e77. doi: 10.2196/resprot.5450.

2.

Defeatist Performance Beliefs, Negative Symptoms, and Functional Outcome in Schizophrenia: A Meta-analytic Review.

Campellone TR, Sanchez AH, Kring AM.

Schizophr Bull. 2016 Nov;42(6):1343-1352. Epub 2016 Mar 15. Review.

PMID:
26980144
3.

Inefficient effort allocation and negative symptoms in individuals with schizophrenia.

McCarthy JM, Treadway MT, Bennett ME, Blanchard JJ.

Schizophr Res. 2016 Feb;170(2-3):278-84. doi: 10.1016/j.schres.2015.12.017. Epub 2016 Jan 4.

4.

Social cognition in schizophrenia: factor structure, clinical and functional correlates.

Buck BE, Healey KM, Gagen EC, Roberts DL, Penn DL.

J Ment Health. 2016 Aug;25(4):330-337. Epub 2016 Jan 8.

5.
6.

Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF.

Schizophr Bull. 2015 Sep;41(5):1055-65. doi: 10.1093/schbul/sbv090. Epub 2015 Jul 23.

7.

Structure and correlates of self-reported empathy in schizophrenia.

Horan WP, Reise SP, Kern RS, Lee J, Penn DL, Green MF.

J Psychiatr Res. 2015 Jul-Aug;66-67:60-6. doi: 10.1016/j.jpsychires.2015.04.016. Epub 2015 Apr 30.

8.

Observable Social Cognition--A Rating Scale: an interview-based assessment for schizophrenia.

Healey KM, Combs DR, Gibson CM, Keefe RS, Roberts DL, Penn DL.

Cogn Neuropsychiatry. 2015;20(3):198-221. doi: 10.1080/13546805.2014.999915. Epub 2015 Feb 13.

9.

Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI.

Schizophr Res. 2015 Apr;163(1-3):63-72. doi: 10.1016/j.schres.2014.09.042. Epub 2014 Oct 23.

10.

Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications.

Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2015 Apr;163(1-3):24-31. doi: 10.1016/j.schres.2014.08.014. Epub 2014 Sep 22.

11.

Behavioral approach and avoidance in schizophrenia: an evaluation of motivational profiles.

Felice Reddy L, Green MF, Rizzo S, Sugar CA, Blanchard JJ, Gur RE, Kring AM, Horan WP.

Schizophr Res. 2014 Oct;159(1):164-70. doi: 10.1016/j.schres.2014.07.047. Epub 2014 Aug 19.

12.

The use of narrative sampling in the assessment of social cognition: the Narrative of Emotions Task (NET).

Buck B, Ludwig K, Meyer PS, Penn DL.

Psychiatry Res. 2014 Jul 30;217(3):233-9. doi: 10.1016/j.psychres.2014.03.014. Epub 2014 Mar 25.

13.

Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity.

Olbert CM, Penn DL, Kern RS, Lee J, Horan WP, Reise SP, Ochsner KN, Marder SR, Green MF.

Schizophr Bull. 2013 Nov;39(6):1211-8. doi: 10.1093/schbul/sbt130. Epub 2013 Sep 26.

14.

Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr.

J Psychiatr Res. 2013 Jun;47(6):783-90. doi: 10.1016/j.jpsychires.2013.01.015. Epub 2013 Feb 27.

15.

The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP.

Am J Psychiatry. 2013 Feb;170(2):165-72. doi: 10.1176/appi.ajp.2012.12010109.

16.

The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.

Llerena K, Park SG, McCarthy JM, Couture SM, Bennett ME, Blanchard JJ.

Compr Psychiatry. 2013 Jul;54(5):568-74. doi: 10.1016/j.comppsych.2012.12.001. Epub 2013 Jan 22.

17.

From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Green MF, Hellemann G, Horan WP, Lee J, Wynn JK.

Arch Gen Psychiatry. 2012 Dec;69(12):1216-24. doi: 10.1001/archgenpsychiatry.2012.652.

18.

A dual change model of life satisfaction and functioning for individuals with schizophrenia.

Edmondson M, Pahwa R, Lee KK, Hoe M, Brekke JS.

Schizophr Res. 2012 Aug;139(1-3):110-5. doi: 10.1016/j.schres.2012.04.014. Epub 2012 May 14.

19.

Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?

Bell MD, Corbera S, Johannesen JK, Fiszdon JM, Wexler BE.

Schizophr Bull. 2013 Jan;39(1):186-96. doi: 10.1093/schbul/sbr125. Epub 2011 Oct 5.

20.

Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients.

Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH.

Schizophr Bull. 2012 Jun;38(4):865-72. doi: 10.1093/schbul/sbr001. Epub 2011 Mar 7.

Supplemental Content

Support Center